{
    "title": "111_hr3156",
    "content": "Section 1 introduces a new credit for non-clinical testing expenses related to neglected disease treatments under the Internal Revenue Code of 1986. The new credit introduced under the Internal Revenue Code of 1986 allows for a 50 percent credit on qualified non-clinical research expenses incurred during the taxable year. Qualified expenses are those related to non-clinical research and require the donation of rights to treatment. The new credit introduced under the Internal Revenue Code of 1986 allows for a 50 percent credit on qualified non-clinical research expenses incurred during the taxable year. To qualify for the credit, the taxpayer must have made a charitable contribution of a license for the treatment with respect to which the expenses were paid or incurred. The charitable contribution must be made to a charitable organization researching, developing, or administering treatments for neglected conditions. The new credit introduced under the Internal Revenue Code of 1986 allows for a 50 percent credit on qualified non-clinical research expenses incurred during the taxable year. The taxpayer must have made a charitable contribution to a charitable organization researching, developing, or administering treatments for neglected conditions. The contribution must be made for exclusively public purposes, with no commercial rights retained by the taxpayer. Non-clinical research refers to research for neglected diseases like African trypanosomiasis, dengue fever, malaria, and others. The text chunk discusses the designation of certain infectious diseases as neglected diseases that disproportionately affect poor and marginalized populations. Rules similar to other tax regulations apply, and these diseases can be treated as trade or business expenses. The text chunk discusses the treatment of qualified non-clinical research expenses as trade or business expenses, without considering licensing rights contributions. It also mentions that limitations under section 280C do not apply when determining deductibility of expenses. These expenses can be part of the general business credit. The text chunk amends the code by adding a new paragraph related to neglected disease credit under section 45R. Additionally, a clerical amendment is made to the table of sections for subpart D of part IV of subchapter A of chapter 1 of the Code. The amendment adds a new section for non-clinical testing expenses for neglected disease treatments, effective for taxable years starting after December 31, 2009."
}